Skip to content
USPeptideRxLearnApply for an account

Glossary

Terminal distributor of dangerous drugs (TDDD): the licence the receiving practice needs

USPeptideRx EditorialLast reviewed:

A terminal distributor of dangerous drugs licence is Ohio’s authorisation for a business entity to purchase, possess, administer or distribute dangerous drugs at a specific location, and the Ohio Board of Pharmacy states in its own guidance that prescriber practices are among the entities it covers. It is the clearest example of a requirement prescribers routinely miss: the credential is not only the supplier’s problem, because the practice taking delivery may need one of its own. Ohio’s guidance also says the usual exemptions from that licensure generally stop applying once a practice is engaged in compounding — with a named carve-out for merely possessing preparations supplied by a licensed outsourcing facility.

The definition, from the Board’s own guidance

Ohio’s Board of Pharmacy states it plainly in the guidance written for prescribers who compound:

Ohio Board of Pharmacy — Terminal Distributor Requirements for Prescribers Engaged in Drug Compounding, updated 13 January 2025
A Terminal Distributor of Dangerous Drugs (TDDD) license allows a business entity to purchase, possess, administer, and/or distribute dangerous drugs at a specific location. A terminal distributor of dangerous drugs includes hospitals, pharmacies, EMS organizations, laboratories, nursing homes, and prescriber practices.

Two details do the work. The licence is tied to a specific location, so it is a per-site credential rather than a business-wide one. And prescriber practices are named in the list, which is what makes this a buyer-side question rather than a supplier-side one.

The same document describes what "dangerous drugs" reaches: a drug that requires a prescription, or bears a federal legend on its label, or is intended for injection into the human body. That last limb is why the question arrives for injectables specifically.

Compounding removes the usual exemptions

The Board’s guidance is direct about what changes when a practice compounds:

Ohio Board of Pharmacy — Terminal Distributor Requirements for Prescribers Engaged in Drug Compounding
In general, the exemptions to Ohio's TDDD licensure requirements do not apply if the prescriber practice is engaged in drug compounding.

The Board then names lower-risk activities that do not trigger licensure, and one of them is the case a prescriber buying finished stock is actually in:

Ohio Board of Pharmacy — Terminal Distributor Requirements for Prescribers Engaged in Drug Compounding, carve-out 4
The possession of compounded drug preparations provided by an Ohio licensed outsourcing facility. (NOTE: If a prescriber compounds any sterile drug received from an outsourcing facility, the prescriber office is subject to licensure as a TDDD).

Read the note, not just the carve-out. Possessing finished preparations is one thing; doing anything to them on arrival is another, and the Board’s guidance elsewhere adds that preparing medications in advance of administration requires licensure and compliance with its compounding rules. Reconstituting or diluting at the point of administration and holding a prepared syringe for later are different acts under this rule.

The same question in other states

There is no national answer, and the trigger is often the entity rather than the practice. Florida requires a health care clinic establishment permit for the purchase of a prescription drug by a business entity with its own federal employer tax identification number, while expressly excluding a purchase made by a licensed practitioner under their own licence — so the same clinic can need a permit or not depending on whose name is on the account. California lets dangerous drugs be provided to a physician directly, but a clinic falling within its licensed-clinic categories takes on a separate per-location permit with a consulting pharmacist attached.

Several of the states reviewed on this site impose no such requirement on a practice at all. What matters is that this is a third credential, separate from the supplier’s two: whether a supplier may ship is non-resident pharmacy licence, whether it may supply stock naming no patient is 503B outsourcing facility, and whether you may take delivery is this one. The practical ordering sequence that runs all three is how to place an office-use order; what the arrangement itself is called is office use.

What this page does not establish

  • The definitions quoted are the Ohio Board of Pharmacy’s own guidance wording, attributed to the guidance document and its date. The statutory definitions in the Ohio Revised Code were not retrieved, and the Board’s two guidance documents word the definition differently from one another — the later one is quoted here.
  • The exemptions from Ohio licensure are referred to by the Board but their text was not retrieved. This page therefore cannot answer whether any particular practice is exempt, only that the Board says compounding generally removes the exemptions.
  • Ohio’s own position on supplying a prescriber with human office stock is internally contested and unresolved between its statute and its rules, and nothing here should be read as describing that arrangement as settled. The route this page describes is the receiving practice’s licence, which is a separate question.
  • Whether a practice needs a permit elsewhere depends on the state and on the entity that buys — the analogues named here come from states with a completed primary-source briefing on this site, and several reviewed states impose no such requirement at all. States not reviewed are unknown.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.

  1. [1]Ohio Board of Pharmacy — Terminal Distributor Requirements for Prescribers Engaged in Drug Compounding (PDF, updated 13 January 2025)
  2. [2]Ohio Board of Pharmacy — Terminal Distributor Licensure of Prescriber Practices (PDF)
  3. [3]ORC 4729.01 — Ohio pharmacy definitions
  4. [4]Fla. Stat. § 499.01 — permits, including the health care clinic establishment permit
  5. [5]Cal. Bus. & Prof. Code § 4059.5 — who may be provided dangerous drugs